Aminophylline Injection – Manufacturer, Exporter & Supplier
What is Aminophylline Injection?
Aminophylline Injection is a xanthine derivative and bronchodilator used in the treatment of asthma, chronic bronchitis, emphysema, and other obstructive airway diseases. It is a complex of theophylline with ethylenediamine, which improves solubility and absorption. Aminophylline is widely used in emergency and hospital care to relieve bronchospasm and breathing difficulty.
Uses of Aminophylline Injection
- Emergency treatment of acute asthma attacks
- Management of bronchospasm in COPD
- Supportive therapy in status asthmaticus
- Treatment of apnea of prematurity (under specialist care)
- Adjunctive therapy in pulmonary edema due to heart failure
How Does Aminophylline Injection Work?
Aminophylline works by relaxing bronchial smooth muscles through phosphodiesterase inhibition, which increases cyclic AMP levels. It also blocks adenosine receptors, reducing airway constriction. Together, these effects result in bronchodilation, improved airflow, and better oxygenation.
FAQs on Aminophylline Injection
Q1: What is Aminophylline Injection used for?
It is used to treat acute asthma attacks, COPD exacerbations, and bronchospasm in emergency settings.
Q2: How is Aminophylline administered?
It is usually given by slow intravenous injection or infusion under medical supervision.
Q3: What strengths and packs does Farbe Firma supply?
We supply 25 mg/ml Aminophylline Injection (250 mg/10 ml) in ampoules/vials, customizable for international markets.
Q4: Does Farbe Firma provide regulatory documentation?
Yes, we provide CTD/ACTD dossiers, COPP, and registration assistance for smooth global approvals.
Looking for a reliable Aminophylline Injection manufacturer?
Contact Farbe Firma Pvt. Ltd. for trusted bronchodilator injectables, dossier support, and seamless export supplies.
Product Name
Aminophylline Injection
Trade Name
Aminosyl
Available Strength
25 mg/ml
Packing
10 ml, 25 ml
Therapeutic Use
Bronchodilator – asthma, chronic obstructive pulmonary disease (COPD), apnea management

